{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "21-year-old Chinese male diagnosed with stage IV lung adenocarcinoma in February 2016. Metastases in cervical, hilar and mediastinal lymph nodes, and pericardial effusion. Tumor size 1.5 cm by 1.5 cm.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0024117",
              "label": "Lung Adenocarcinoma",
              "status": "active",
              "onset_date": "2016-02"
            }
          ],
          "imaging": [
            {
              "type": "Metastasis",
              "body_part": "Cervical Lymph Nodes",
              "modality": "imaging",
              "finding": "Metastases",
              "impression": "Metastases in cervical lymph nodes",
              "date": "2016-02"
            },
            {
              "type": "Metastasis",
              "body_part": "Hilar Lymph Nodes",
              "modality": "imaging",
              "finding": "Metastases",
              "impression": "Metastases in hilar lymph nodes",
              "date": "2016-02"
            },
            {
              "type": "Metastasis",
              "body_part": "Mediastinal Lymph Nodes",
              "modality": "imaging",
              "finding": "Metastases",
              "impression": "Metastases in mediastinal lymph nodes",
              "date": "2016-02"
            }
          ],
          "HPI": [
            {
              "summary": "Diagnosed with stage IV lung adenocarcinoma in February 2016. Tumor size 1.5 cm by 1.5 cm.",
              "onset": "2016-02"
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Cervical lymph node biopsy performed.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Biopsy of cervical lymph node",
              "approach": "other",
              "location": "Cervical lymph node"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Comprehensive genomic profiling using next generation sequencing (NGS) by targeting 382 cancer-relevant genes on baseline lymph node biopsy specimen, pericardial effusion ctDNA, and plasma ctDNA samples. No actionable driver mutations were detected in any sample.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Pericardial effusion",
              "body_part": "Pericardium",
              "modality": "CT",
              "finding": "ctDNA",
              "impression": "No actionable driver mutations detected",
              "date": null
            }
          ],
          "procedures": [
            {
              "name": "Biopsy",
              "approach": "other",
              "date": null,
              "location": "Lymph node",
              "performed_by": null,
              "outcome": "No actionable driver mutations detected"
            }
          ],
          "labs": [
            {
              "test": "Comprehensive genomic profiling",
              "value": "No actionable driver mutations detected",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Received six cycles of first-line chemotherapy with pemetrexed (500 mg/m2) and cisplatin (75 mg/m2), resulting in a partial response (PR) per RECIST 1.1 guidelines.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0889340",
              "dosage": "500 mg/m2",
              "frequency": "every cycle",
              "modality": "IV",
              "indication": "Malignant Neoplasm",
              "start_date": null,
              "end_date": null
            },
            {
              "drug": "C0008833",
              "dosage": "75 mg/m2",
              "frequency": "every cycle",
              "modality": "IV",
              "indication": "Malignant Neoplasm",
              "start_date": null,
              "end_date": null
            }
          ],
          "procedures": [
            {
              "name": "Partial Response",
              "approach": null,
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Post-chemotherapy plasma ctDNA sample tested in August 2016 using NGS with a targeted gene panel showed no mutation detected.",
        "clinical_data": {
          "labs": [
            {
              "test": "ctDNA",
              "value": "no mutation detected",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": "2016-08"
            }
          ],
          "procedures": [
            {
              "name": "Next Generation Sequencing",
              "approach": null,
              "date": "2016-08",
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Continued maintenance chemotherapy with ten cycles of pemetrexed (500 mg/m2).",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0974187",
              "dosage": "500 mg/m2",
              "frequency": "every 21 days",
              "modality": "IV",
              "indication": "Maintenance chemotherapy"
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Disease progression with bone metastases detected in October 2017. Primary lung lesion remained stable.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C79.51",
              "label": "Secondary malignant neoplasm of bone",
              "status": "active",
              "onset_date": "2017-10"
            }
          ],
          "imaging": [
            {
              "type": "Finding",
              "body_part": "Bone",
              "modality": "other",
              "finding": "Metastases",
              "impression": "Disease progression",
              "date": "2017-10"
            },
            {
              "type": "Lesion",
              "body_part": "Lung",
              "modality": "other",
              "finding": "Primary lung lesion",
              "impression": "Stable",
              "date": "2017-10"
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "FFPE (cervical lymph node) analysis at diagnosis (February 20",
        "clinical_data": {
          "procedures": [
            {
              "name": "Analysis",
              "date": "2020-02",
              "location": "Cervical Lymph Node"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Decision to perform cervical lymph node biopsy."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Cervical lymph node biopsy specimen sent for comprehensive genomic profiling using next generation sequencing (NGS) by targeting 382 cancer-relevant genes on baseline lymph node biopsy specimen, pericardial effusion ctDNA, and plasma ctDNA samples."
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Initiation of first-line chemotherapy with pemetrexed and cisplatin.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0889340",
            "C0008833"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Post-chemotherapy assessment of plasma ctDNA using NGS.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [],
          "change_type": "other",
          "target_domain": "lab"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Continuation of maintenance chemotherapy with pemetrexed.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0974187"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Disease progression with bone metastases detected.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C79.51"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis",
          "timestamp": "2017-10"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "FFPE (cervical lymph node) analysis at diagnosis.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [],
          "change_type": "other",
          "target_domain": "procedure",
          "timestamp": "2020-02"
        }
      }
    }
  ]
}